Jie Jenny Chen serves as the Associate Scientific Director and Companion Diagnostic Strategy Lead at AbbVie, where she leverages her extensive expertise in in vitro diagnostics (IVD) and companion diagnostic (CDx) product development to drive innovative solutions in oncology. With a strong foundation in histology,...
Jie Jenny Chen serves as the Associate Scientific Director and Companion Diagnostic Strategy Lead at AbbVie, where she leverages her extensive expertise in in vitro diagnostics (IVD) and companion diagnostic (CDx) product development to drive innovative solutions in oncology. With a strong foundation in histology, immunohistochemistry, biochemistry, and cancer biology, Jenny plays a pivotal role in shaping diagnostic strategies that enhance patient selection for global clinical trials. Her current projects focus on developing and implementing CDx assays that facilitate targeted therapies for complex hematological malignancies, including non-Hodgkin's lymphoma and multiple myeloma.
In her role, Jenny is responsible for designing comprehensive patient selection strategies that integrate cutting-edge genomic and genetic insights, ensuring that the right patients receive the right treatments at the right time. Her proficiency in utilizing advanced techniques such as RNA interference (RNAi), immunoprecipitation, and mouse models enables her to explore novel biomarkers and therapeutic targets, ultimately contributing to the advancement of personalized medicine. Jenny's results-driven approach and willingness to tackle new challenges have positioned her as a key leader in the development of diagnostic strategies that not only improve clinical outcomes but also align with AbbVie's commitment to transforming patient care.
As a motivated translational scientist, Jenny is dedicated to bridging the gap between laboratory research and clinical application, ensuring that innovative CDx solutions are effectively integrated into clinical practice. Her work exemplifies the critical role of companion diagnostics in oncology, paving the way for more precise and effective treatment interventions that enhance patient survival and quality of life.
